Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason S Knight

Showing results (41-50 of 161) with videos related to

Pageof 17
Sort By:
Journal of Virology|July 15, 2005
Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1Daniel A Kuppers, Ke Lan, Jason S Knight, et al.
Thrombosis Research|September 3, 2023
Transcriptome analysis suggests a central role for complement and C5aR1 in neutrophil activation in APSAhmed Alarabi, Anne Hubben, John Barnard, et al.
Current Opinion in Rheumatology|February 13, 2019
Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndromeAndrew P Vreede, Paula L Bockenstedt, W Joseph McCune, et al.
International Journal of Molecular Sciences|April 3, 2021
Understanding the Pathophysiology of Thrombotic APS through Animal ModelsAlex A Gandhi, Shanea K Estes, Christine E Rysenga, et al.
Pediatric Rheumatology Online Journal|February 24, 2022
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case seriesJacqueline A Madison, Kelsey Gockman, Claire Hoy, et al.
Plos Pathogens|October 31, 2006
EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressorsQi-Liang Cai, Jason S Knight, Suhbash C Verma, et al.
Arthritis Care & Research|December 20, 2016
A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe IschemiaNayef M Kazzaz, Allecia M Wilson, Ruba Kado, et al.
Expert Review of Clinical Immunology|March 9, 2021
Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsetsIrene Cecchi, Massimo Radin, Javier Rodríguez-Carrio, et al.
Rheumatology (Oxford, England)|October 10, 2023
Taxifolin inhibits NETosis through activation of Nrf2 and provides protective effects in models of lupus and antiphospholipid syndromeChristine E Rysenga, Linda May-Zhang, Miela Zahavi, et al.
Clinical Immunology (Orlando, Fla.)|November 25, 2018
Genome-wide DNA methylation analysis in primary antiphospholipid syndrome neutrophilsEmma Weeding, Patrick Coit, Srilakshmi Yalavarthi, et al.
Pageof 17

Showing results (41-50 of 161) with videos related to

Sort By:
Pageof 17
Journal of Virology|July 15, 2005
Regulation of matrix metalloproteinase 9 expression by Epstein-Barr virus nuclear antigen 3C and the suppressor of metastasis Nm23-H1Daniel A Kuppers, Ke Lan, Jason S Knight, et al.
Thrombosis Research|September 3, 2023
Transcriptome analysis suggests a central role for complement and C5aR1 in neutrophil activation in APSAhmed Alarabi, Anne Hubben, John Barnard, et al.
Current Opinion in Rheumatology|February 13, 2019
Cryptic conspirators: a conversation about thrombocytopenia and antiphospholipid syndromeAndrew P Vreede, Paula L Bockenstedt, W Joseph McCune, et al.
International Journal of Molecular Sciences|April 3, 2021
Understanding the Pathophysiology of Thrombotic APS through Animal ModelsAlex A Gandhi, Shanea K Estes, Christine E Rysenga, et al.
Pediatric Rheumatology Online Journal|February 24, 2022
Pediatric antiphospholipid syndrome: clinical features and therapeutic interventions in a single center retrospective case seriesJacqueline A Madison, Kelsey Gockman, Claire Hoy, et al.
Plos Pathogens|October 31, 2006
EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressorsQi-Liang Cai, Jason S Knight, Suhbash C Verma, et al.
Arthritis Care & Research|December 20, 2016
A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe IschemiaNayef M Kazzaz, Allecia M Wilson, Ruba Kado, et al.
Expert Review of Clinical Immunology|March 9, 2021
Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsetsIrene Cecchi, Massimo Radin, Javier Rodríguez-Carrio, et al.
Rheumatology (Oxford, England)|October 10, 2023
Taxifolin inhibits NETosis through activation of Nrf2 and provides protective effects in models of lupus and antiphospholipid syndromeChristine E Rysenga, Linda May-Zhang, Miela Zahavi, et al.
Clinical Immunology (Orlando, Fla.)|November 25, 2018
Genome-wide DNA methylation analysis in primary antiphospholipid syndrome neutrophilsEmma Weeding, Patrick Coit, Srilakshmi Yalavarthi, et al.
Pageof 17